Tuesday 15 July 2014   13:30 – 15:00
Track 3 - Renin-angiotensin system pharmacology revisited

Chair: Jan Danser

Blockade of prorenin, renin and the (pro)renin receptor: too much of a good thing?
Jan Danser

Novel domain-selective ACE inhibitors: antihypertensives or antifibrotics?
Edward Sturrock

The AT2 receptor as a drug target: should we stimulate it or block it?
Ulriche Muscha Steckelings

How to activate the ACE2-angiotensin-(1-7)-Mas axis.
Robson Santos